Compositions and methods for cancer diagnosis

NZ837720APending Publication Date: 2026-10-30AOA DX
View PDF 0 Cites 0 Cited by

Patent Information

Application Number
NZ837720
Authority / Receiving Office
NZ · NZ
Patent Type
Applications
Current Assignee / Owner
Priority Date
2020-10-05
Filing Date
2021-10-05
Publication Date
2026-10-30

Smart Images

  • Figure 00000156_0000
    Figure 00000156_0000
  • Figure 00000156_0001
    Figure 00000156_0001
  • Figure 00000156_0002
    Figure 00000156_0002
Patent Text Reader

Abstract

The present disclosure provides monoclonal antibodies and antigen-binding fragments thereof that specifically bind to gangliosides (e.g., GD2 or GD3), as well as compositions comprising same and methods of using same for diagnostic and prognostic purposes. In addition, the present disclosure provides mass spectrometry-based methods for detecting various gangliosides and their lipid length, the changes of which are useful for the cancer diagnostic and prognostic methods described herein. The present disclosure further provides compounds comprising modified versions of gangliosides.
Need to check novelty before this filing date? Find Prior Art